128 related articles for article (PubMed ID: 32941675)
21. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model.
Wang X; Zhang J; Zhou L; Lu P; Zheng ZG; Sun W; Wang JL; Yang XS; Li XL; Xia N; Zhang N; Dou KF
Int J Clin Exp Pathol; 2015; 8(2):1466-78. PubMed ID: 25973032
[TBL] [Abstract][Full Text] [Related]
22. Study on the relationship between miR-520g and the development of breast cancer.
Ren GB; Wang L; Zhang FH; Meng XR; Mao ZP
Eur Rev Med Pharmacol Sci; 2016; 20(4):657-63. PubMed ID: 26957267
[TBL] [Abstract][Full Text] [Related]
23. Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer.
Liu X; Chang Q; Wang H; Qian H; Jiang Y
Breast Cancer; 2021 Jul; 28(4):806-821. PubMed ID: 33475963
[TBL] [Abstract][Full Text] [Related]
24. Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.
Shahabi A; Naghili B; Ansarin K; Montazeri M; Dadashpour M; Zarghami N
Asian Pac J Cancer Prev; 2021 Jan; 22(1):305-313. PubMed ID: 33507713
[TBL] [Abstract][Full Text] [Related]
25. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
[TBL] [Abstract][Full Text] [Related]
26. [Expression of microRNA-21 in invasive ductal carcinoma of the breast and its association with phosphatase and tensin homolog deleted from chromosome expression and clinicopathologic features].
Huang GL; Zhang XH; Guo GL; Huang KT; Yang KY; Hu XQ
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2833-7. PubMed ID: 19080492
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
28. PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer.
Li RK; Gao J; Guo LH; Huang GQ; Luo WH
Cancer Gene Ther; 2017 Jul; 24(7):309-315. PubMed ID: 28731027
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
Elghoroury EA; ElDine HG; Kamel SA; Abdelrahman AH; Mohammed A; Kamel MM; Ibrahim MH
Clin Breast Cancer; 2018 Aug; 18(4):e721-e726. PubMed ID: 29292183
[TBL] [Abstract][Full Text] [Related]
30. Circulatory miRNA-155, miRNA-21 target PTEN expression and activity as a factor in breast cancer development.
Ali SA; Abdulrahman ZFA; Faraidun HN
Cell Mol Biol (Noisy-le-grand); 2020 Oct; 66(7):44-50. PubMed ID: 33287921
[TBL] [Abstract][Full Text] [Related]
31. Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients.
Khalighfard S; Alizadeh AM; Irani S; Omranipour R
Sci Rep; 2018 Dec; 8(1):17981. PubMed ID: 30568292
[TBL] [Abstract][Full Text] [Related]
32. miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation.
Li B; Lu Y; Yu L; Han X; Wang H; Mao J; Shen J; Wang B; Tang J; Li C; Song B
Chem Biol Interact; 2017 Nov; 277():33-42. PubMed ID: 28844858
[TBL] [Abstract][Full Text] [Related]
33. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
[TBL] [Abstract][Full Text] [Related]
34. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
[TBL] [Abstract][Full Text] [Related]
35. A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.
Wang DY; Gendoo DMA; Ben-David Y; Woodgett JR; Zacksenhaus E
Breast Cancer Res; 2019 Jan; 21(1):18. PubMed ID: 30704524
[TBL] [Abstract][Full Text] [Related]
36. Presence of Circulating miR-145, miR-155, and miR-382 in Exosomes Isolated from Serum of Breast Cancer Patients and Healthy Donors.
Gonzalez-Villasana V; Rashed MH; Gonzalez-Cantú Y; Bayraktar R; Menchaca-Arredondo JL; Vazquez-Guillen JM; Rodriguez-Padilla C; Lopez-Berestein G; Resendez-Perez D
Dis Markers; 2019; 2019():6852917. PubMed ID: 30891102
[TBL] [Abstract][Full Text] [Related]
37. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.
Motawi TK; Rizk SM; Ibrahim TM; Ibrahim IA
Cell Biochem Funct; 2016 Apr; 34(3):142-8. PubMed ID: 26916216
[TBL] [Abstract][Full Text] [Related]
38. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
[TBL] [Abstract][Full Text] [Related]
39. Circulating miR-200c and miR-141 and outcomes in patients with breast cancer.
Antolín S; Calvo L; Blanco-Calvo M; Santiago MP; Lorenzo-Patiño MJ; Haz-Conde M; Santamarina I; Figueroa A; Antón-Aparicio LM; Valladares-Ayerbes M
BMC Cancer; 2015 Apr; 15():297. PubMed ID: 25885099
[TBL] [Abstract][Full Text] [Related]
40. Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer.
Gu X; Xue JQ; Han SJ; Qian SY; Zhang WH
Cancer Biomark; 2016; 16(3):395-403. PubMed ID: 27062696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]